Home -> Law Blog Directory -> Intellectual Property Law Blogs -> IPKat
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: IPKatCiting prior art in European patent applications
By Johanna Gibson, David Pearce, Jeremy Phillips and Ilanah Simon.
Patent attorneys will be well aware that not mentioning relevant prior art known at the time of filing cannot of itself make a European application or patent invalid. The examiners for application 06024212.0, however, apparently thought differently, contrary to long-standing EPO practice. From a rather strained interpretation of the German version of the relevant rule, the examining division's view was that not including a reference to relevant prior art known to the applicant at the time of filing would make the application void ab initio. The application was refused as a result. The applicant, Samsung Electronics, unsurprisingly appealed.
In the resulting decision T 2321/08, the Board considered that the examining division had got it completely wrong. Rule 42(1)(b) did not put any stringent obligation on the applicant to cite relevant documents known at the time of filing, and failure to do so was in any case correctable after filing by making appropriate amendments. There was no reason to depart from the long-standing EPO practice of allowing amendments to be made to the description to cite relevant documents.
The IPKat wonders what on Earth the examining division in this case were thinking of, but is very glad that the Board reached the decision they did, not least because the consequences of the decision going the other way would have been very bad indeed. The well-known consequences in the US of not citing relevant documents are bad enough, but following the examining division's reasoning in this case would inevitably result in many currently pending European applications and granted patents becoming invalid without any hope of recovery. Following the decisions in G 1/05 and G 1/06, the IPKat finds it surprising that an examining division could even contemplate such a draconian interpretation of the rules.
Full post as published by IPKat on June 26, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Federal Government
Florida residents sue claiming extraordinary delays in judging citizenship applications.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
European Style Smoked Salmon
Recalled due to Possible Listeria Contamination
Windows Software
Microsoft fined $1.3 billion for failing to comply with the European Union's antitrust order.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.

European Patent Office: Patent Applications Slow As Rejections Rise
Filing Patent Applications Early in Europe Could Save You Money
European Patent Office limits division of patent applications
EPO Rule Changes: Speeding Prosecution
Intramurals: The European Patent Divide
The Former Yugoslav Republic of Macedonia Accedes to the EPC









